These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11349754)

  • 1. Seizure activity and unresponsiveness after hydroxycut ingestion.
    Kockler DR; McCarthy MW; Lawson CL
    Pharmacotherapy; 2001 May; 21(5):647-51. PubMed ID: 11349754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.
    Haller CA; Benowitz NL
    N Engl J Med; 2000 Dec; 343(25):1833-8. PubMed ID: 11117974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS; Stricker BH
    Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
    Haller CA; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 2002 Jun; 71(6):421-32. PubMed ID: 12087345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.
    Gurley BJ; Steelman SC; Thomas SL
    Clin Ther; 2015 Feb; 37(2):275-301. PubMed ID: 25262198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
    Haller CA; Duan M; Benowitz NL; Jacob P
    J Anal Toxicol; 2004 Apr; 28(3):145-51. PubMed ID: 15107143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the stimulant content of dietary supplements marketed as "ephedra-free".
    Gregory PJ
    J Herb Pharmacother; 2007; 7(1):65-72. PubMed ID: 17594988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute psychosis due to the interaction of legal compounds--ephedra alkaloids in 'vigueur fit' tablets, caffeine in 'red bull' and alcohol.
    Tormey WP; Bruzzi A
    Med Sci Law; 2001 Oct; 41(4):331-6. PubMed ID: 11693229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.
    Mehendale SR; Bauer BA; Yuan CS
    Am J Chin Med; 2004; 32(1):1-10. PubMed ID: 15154280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of ephedra alkaloid and caffeine concentrations in dietary supplements and biological fluids.
    Jacob P; Haller CA; Duan M; Yu L; Peng M; Benowitz NL
    J Anal Toxicol; 2004 Apr; 28(3):152-9. PubMed ID: 15107144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complicated hypertension related to the abuse of ephedrine and caffeine alkaloids.
    Berman JA; Setty A; Steiner MJ; Kaufman KR; Skotzko C
    J Addict Dis; 2006; 25(3):45-8. PubMed ID: 16956868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric effects of ephedra: addiction.
    Miller SC
    Am J Psychiatry; 2005 Nov; 162(11):2198. PubMed ID: 16263877
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA, regulation, and the risk of stroke.
    Fleming GA
    N Engl J Med; 2000 Dec; 343(25):1886-7. PubMed ID: 11117982
    [No Abstract]   [Full Text] [Related]  

  • 14. Ephedra in perspective--a current review.
    Abourashed EA; El-Alfy AT; Khan IA; Walker L
    Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography.
    Gurley BJ; Wang P; Gardner SF
    J Pharm Sci; 1998 Dec; 87(12):1547-53. PubMed ID: 10189265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected caffeine and ephedrine toxicosis resulting from ingestion of an herbal supplement containing guarana and ma huang in dogs: 47 cases (1997-1999).
    Ooms TG; Khan SA; Means C
    J Am Vet Med Assoc; 2001 Jan; 218(2):225-9. PubMed ID: 11195828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of herbal products and symptoms of bipolar disorder.
    Emmanuel NP; Jones C; Lydiard RB
    Am J Psychiatry; 1998 Nov; 155(11):1627. PubMed ID: 9812133
    [No Abstract]   [Full Text] [Related]  

  • 18. Ma-huang strikes again: ephedrine nephrolithiasis.
    Powell T; Hsu FF; Turk J; Hruska K
    Am J Kidney Dis; 1998 Jul; 32(1):153-9. PubMed ID: 9669437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.
    Nadir A; Agrawal S; King PD; Marshall JB
    Am J Gastroenterol; 1996 Jul; 91(7):1436-8. PubMed ID: 8678010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ephedra-free labeled dietary supplements sold in the San Francisco Bay area in 2003.
    Tam JW; Dennehy CE; Ko R; Tsourounis C
    J Herb Pharmacother; 2006; 6(2):1-19. PubMed ID: 17182481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.